Volume 9 Issue 5, May 2024

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 9 Issue 5, May 2024:
Research Highlight
Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response
Svenja Meierjohann &Corine Bertolotto